The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Molecular characterization of a peripheral receptor for cannabinoids
Abstract
The major active ingredient of marijuana, delta 9-tetrahydrocannabinol (delta 9-THC), has been used as a psychoactive agent for thousands of years. Marijuana, and delta 9-THC, also exert a wide range of other effects including analgesia, anti-inflammation, immunosuppression, anticonvulsion, alleviation of intraocular pressure in glaucoma, and attenuation of vomiting. The clinical application of cannabinoids has, however, been limited by their psychoactive effects, and this has led to interest in the biochemical bases of their action. Progress stemmed initially from the synthesis of potent derivatives of delta 9-THC, and more recently from the cloning of a gene encoding a G-protein-coupled receptor for cannabinoids. This receptor is expressed in the brain but not in the periphery, except for a low level in testes. It has been proposed that the nonpsychoactive effects of cannabinoids are either mediated centrally or through direct interaction with other, non-receptor proteins. Here we report the cloning of a receptor for cannabinoids that is not expressed in the brain but rather in macrophages in the marginal zone of spleen.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The primary psychoactive constituent of cannabis, THC (Mechoulam and Gaoni, 1965), and certain other plant-derived or synthetic psychoactive cannabinoids bind cannabinoid (CB 1 and CB 2 ) receptors (Devane et al, 1988;Matsuda et al, 1990;Munro et al, 1993).”
From The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain (2018) · cites this paper as Munro et al, 1993
In the citing paper
“CB1 and CB2 receptors exhibit disparate anatomical distributions.3”
From Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside (2009) · cites this paper as [3]
In the citing paper
“Both CB12 and CB23 receptors are G-coupled protein receptors that are negatively coupled to adenylate cyclase.”
From Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside (2009) · cites this paper as [3]
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
Collins, S. (1987) · Blood · doi:10.1182/blood.v70.5.1233.1233 · Cited by 1,189
The probable arrangement of the helices in G protein‐coupled receptors.
Baldwin, J. M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05814.x · Cited by 968
Molecular cloning of a human cannabinoid receptor which is also expressed in testis
Gérard, C. M., Mollereau, C., Vassart, G., & Parmentier, M. (1991) · Biochemical Journal · doi:10.1042/bj2790129 · Cited by 698
An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2
Seed, B. (1987) · Nature · doi:10.1038/329840a0 · Cited by 674
Mailleux, P., & Vanderhaeghen, J. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90409-u · Cited by 660
Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.
Zhou, Q. Y., Li, C., Olah, M. E., Johnson, R. A., Stiles, G. L., & Civelli, O. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7432 · Cited by 659
ICAM, an adhesion ligand of LFA-1, is homologous to the neural cell adhesion molecule NCAM
Simmons, D., Makgoba, M. W., & Seed, B. (1988) · Nature · doi:10.1038/331624a0 · Cited by 616
Research works printed but not linked: 8
- Dewey, W. L. Pharmac. Rev. 38, 151–178 (1986).
- Hollister, L. E. Pharmac. Rev. 38, 1–20 (1986).
- Razdan, R. K. Pharmac. Rev. 38, 75–149 (1986).
- Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S. & Howlett, A. C. Molec. Pharmacol. 34, 605–613 (1988).
- Martin, B. R. Pharmac. Rev. 38, 45–74 (1986).
- Reichman, M., Nen, W. & Hokin, L. E. Molec. Pharmac. 40, 547–555 (1991).
- Munson, A. E. & Fehr, K. O. in Adverse Health and Behavioral Consequences of Cannabis Use (eds Fehr, K. O. & Kalant H.) 257–353 (Addiction Research Foundation, Toronto, 1983).
- Robinson, A. P., White, T. M. & Mason, D. W. Immunology 57, 239–247 (1986).
Cited by
Sorted by citations
Items 301–400 of 1,038
Impact of the Autonomic Nervous System on the Skeleton
Elefteriou, F. (2018) · Physiological Reviews · doi:10.1152/physrev.00014.2017 · Cited by 248
Cannabinoids and the immune system: An overview
Tănăsescu, R., & Constantinescu, C. S. (2010) · Immunobiology · doi:10.1016/j.imbio.2009.12.005 · Cited by 246
Cannabinoid Receptor as a Novel Target for the Treatment of Prostate Cancer
Sarfaraz, S., Afaq, F., Adhami, V. M., & Mukhtar, H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3410 · Cited by 248
Comparative Receptor Binding Analyses of Cannabinoid Agonists and Antagonists
Thomas, B. F., Gilliam, A. F., Burch, D. F., Roche, M. J., & Seltzman, H. H. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37365-3 · Cited by 245
Gloss, D. S., & Vickrey, B. G. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009270.pub3 · Cited by 244
Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide
Calignano, A., Rana, G. L., & Piomelli, D. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00988-8 · Cited by 243
Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation
Rom, S., & Persidsky, Y. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9445-9 · Cited by 244
Therapeutic Potential of Cannabinoids in CNS Disease
Croxford, J. L. (2003) · CNS Drugs · doi:10.2165/00023210-200317030-00004 · Cited by 241
The endocannabinoid system: an overview
Battista, N., Tommaso, M. D., Bari, M., & Maccarrone, M. (2012) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2012.00009 · Cited by 241
Cannabinoid receptors in microglia of the central nervous system: immune functional relevance
Cabral, G. A., & Marciano‐Cabral, F. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0405216 · Cited by 241
Mato, S., del Olmo, E., & Pazos, Á. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02599.x · Cited by 241
Cannabinoid CB 1 and CB 2 Receptor Signaling and Bias
Ibsen, M. S., Connor, M. A., & Glass, M. (2017) · Cannabis and Cannabinoid Research · doi:10.1089/can.2016.0037 · Cited by 240
Ferber, S. G., Namdar, D., Hen-Shoval, D., Eger, G., Koltai, H., Shoval, G., Shbiro, L., & Weller, A. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666190903103923 · Cited by 239
Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models
Malone, D. T., Hill, M. N., & Rubino, T. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00721.x · Cited by 237
N-Acylethanolamines in human reproductive fluids
Schuel, H., Burkman, L. J., Lippes, J., Crickard, K., Forester, E., Piomelli, D., & Giuffrida, A. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00158-5 · Cited by 236
Felder, C. C., Joyce, K. E., Briley, E. M., Glass, M., Mackie, K., Fahey, K. J., Cullinan, G. J., Hunden, D. C., Johnson, D. W., Chaney, M. O., et al. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37189-7 · Cited by 238
2-Arachidonoylglycerol and the cannabinoid receptors
Sugiura, T., & Waku, K. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00189-4 · Cited by 236
Hill, M. N., & McEwen, B. S. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.11.001 · Cited by 235
Cannabinoid receptors and immunity
Klein, T., Newton, C. A., & Friedman, H. P. (1998) · Immunology Today · doi:10.1016/s0167-5699(98)01300-0 · Cited by 235
Δ9-Tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells
Yuan, M., Kiertscher, S. M., Cheng, Q., Zoumalan, R., Tashkin, D. P., & Roth, M. D. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00370-3 · Cited by 234
Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer
Qamri, Z., Preet, A., Nasser, M. W., Bass, C. E., Leone, G. W., Barsky, S. H., & Ganju, R. K. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0448 · Cited by 234
Cannabinoids Acting on CB1 Receptors Decrease Contractile Performance in Human Atrial Muscle
Bonz, A. W., Laser, M., Küllmer, S., Kniesch, S., Babin–Ebell, J., Popp, V., Ertl, G., & Wagner, J. A. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200304000-00020 · Cited by 234
Hungund, B. L., Vinod, K. Y., Kassir, S. A., Basavarajappa, B. S., Yalamanchili, R., Cooper, T. B., Mann, J. J., & Arango, V. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001376 · Cited by 231
Franklin, A., Parmentier‐Batteur, S., Walter, L. M., Greenberg, D. A., & Stella, N. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-21-07767.2003 · Cited by 232
Sam, A. H., Salem, V., & Ghatei, M. A. (2011) · Journal of Obesity · doi:10.1155/2011/432607 · Cited by 230
Kim, I., & He, Y. (2014) · Genes & Diseases · doi:10.1016/j.gendis.2014.08.005 · Cited by 231
Jekyll and Hyde: Two Faces of Cannabinoid Signaling in Male and Female Fertility
Wang, H., Dey, S. K., & Maccarrone, M. (2006) · Endocrine Reviews · doi:10.1210/er.2006-0006 · Cited by 230
Endocannabinoids and related N-acylethanolamines: biological activities and metabolism
Tsuboi, K., Uyama, T., Okamoto, Y., & Ueda, N. (2018) · Inflammation and Regeneration · doi:10.1186/s41232-018-0086-5 · Cited by 231
Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects
Wallace, M. J., Wiley, J. L., Martin, B. R., & DeLorenzo, R. J. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01243-2 · Cited by 229
Donadelli, M., Dando, I., Zaniboni, T., Costanzo, C., Pozza, E. D., Scupoli, M. T., Scarpa, A., Zappavigna, S., Marra, M., Abbruzzese, A., et al. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.36 · Cited by 229
Hassan, F., Liu, C., Mehboob, M., Bilal, R. M., Arain, M. A., Siddique, F., Chen, F., Li, Y., Zhang, J., Shi, P., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1285052 · Cited by 239
Waksman, Y., Olson, J. M., Carlisle, S. J., & Cabral, G. A. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38093-0 · Cited by 227
An overview of the cannabinoid type 2 receptor system and its therapeutic potential
Bie, B., Wu, J., Foss, J. F., & Naguib, M. (2018) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000616 · Cited by 230
Immunohistochemical localization of the neural cannabinoid receptor in rat brain
Pettit, D. A. D., Harrison, M. P., Olson, J. M., Spencer, R. F., & Cabral, G. A. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19980201)51:3 · Cited by 228
Cannabinoid signaling in glial cells
Stella, N. (2004) · Glia · doi:10.1002/glia.20084 · Cited by 226
Cannabidiol lowers incidence of diabetes in non-obese diabetic mice
Weiss, L., Zeira, M., Reich, S., Har-Noy, M., Mechoulam, R., Slavin, S., & Gallily, R. (2005) · Autoimmunity · doi:10.1080/08916930500356674 · Cited by 226
Cannabinoids in cancer treatment: Therapeutic potential and legislation
Dariš, B., Verboten, M. T., Knez, Ž., & Ferk, P. (2018) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2018.3532 · Cited by 226
The endocannabinoid nervous system
Porter, A. C., & Felder, C. C. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00130-9 · Cited by 226
CB cannabinoid receptor agonists: pain relief without psychoactive effects?
MALANJR, T., IBRAHIM, M., LAI, J., Vanderah, T. W., Makriyannis, A., & Porreca, F. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(02)00004-8 · Cited by 226
Cannabinoids as therapeutic agents in cancer: current status and future implications
Chakravarti, B., Ravi, J., & Ganju, R. K. (2014) · Oncotarget · doi:10.18632/oncotarget.2233 · Cited by 226
Localization of cannabinoid CB1 receptors in the human anterior eye and retina.
Straiker, A. J., Maguire, G., Mackie, K., & Lindsey, J. D. (1999) · PubMed · Cited by 225
Endocannabinoid system and mood disorders: Priming a target for new therapies
Micale, V., Marzo, V. D., Šulcová, A., Wotjak, C. T., & Drago, F. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.12.002 · Cited by 224
Watson, S. J. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.6.547 · Cited by 224
Expression of the cannabinoid CB2 receptor in the rat cerebellum: An immunohistochemical study
Ashton, J. C., Friberg, D., Darlington, C. L., & Smith, P. F. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.11.038 · Cited by 224
Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum
Szabó, B., Dorner, L., Pfreundtner, C., Nörenberg, W., & Starke, K. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00597-6 · Cited by 224
Endocannabinoid Binding to the Cannabinoid Receptors: What Is Known and What Remains Unknown
Reggio, P. H. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790980005 · Cited by 223
Endocannabinoids in the regulation of appetite and body weight
Kirkham, T. C. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200509000-00004 · Cited by 224
Control of the cell survival/death decision by cannabinoids
Guzmán, M., Sánchez, C., & Galve‐Roperh, I. (2000) · Journal of Molecular Medicine · doi:10.1007/s001090000177 · Cited by 223
Cannabinoid receptor type 2 gene is associated with human osteoporosis
Karsak, M., Cohen-Solal, M. E., Freudenberg, J., Ostertag, A., Morieux, C., Kornak, U., Essig, J., Erxlebe, E., Bab, I., Kubisch, C., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi370 · Cited by 222
Citti, C., Linciano, P., Russo, F., Luongo, L., Iannotta, M., Maione, S., Laganà, A., Capriotti, A. L., Forni, F., Vandelli, M. A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-56785-1 · Cited by 222
Retrograde signaling by endocannabinoids
Kreitzer, A. C. (2002) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(02)00328-8 · Cited by 222
Bridges, D., Ahmad, K., & Rice, A. S. C. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704110 · Cited by 222
Barann, M., Molderings, G. J., Brüss, M., Bönisch, H., Urban, B. W., & Göthert, M. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704829 · Cited by 222
Regulation of PI3K/Akt/GSK‐3 pathway by cannabinoids in the brain
Ozaita, A., Puighermanal, E., & Maldonado, R. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04642.x · Cited by 221
Cannabis use in young people: The risk for schizophrenia
Casadio, P., Fernandes, C., Murray, R. M., & Forti, M. D. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.04.007 · Cited by 220
Gut microbiota in overweight and obesity: crosstalk with adipose tissue
Cani, P. D., & Hul, M. V. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00867-z · Cited by 230
New perspectives on enigmatic vanilloid receptors
SZALLASI, A., & Marzo, V. D. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01630-1 · Cited by 220
Targeting CB2 receptors and the endocannabinoid system for the treatment of pain
Anand, P., Whiteside, G. T., Fowler, C. J., & Hohmann, A. G. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.12.003 · Cited by 220
Marijuana and the Cannabinoids
ElSohly, M. A. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-947-9 · Cited by 219
Baron, E. P. (2015) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12570 · Cited by 219
Pertwee, R. G. (2005) · The AAPS Journal · doi:10.1208/aapsj070364 · Cited by 218
The insults of illicit drug use on male fertility
Fronczak, C. M., Kim, E. D., & Barqawi, A. B. (2012) · Journal of Andrology · doi:10.2164/jandrol.110.011874 · Cited by 217
Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning.
Pacher, P., & Haskó, G. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707582 · Cited by 217
Endocannabinoid mechanisms of pain modulation
Hohmann, A. G., & Suplita, R. L. (2006) · The AAPS Journal · doi:10.1208/aapsj080479 · Cited by 217
Zarruk, J. G., Fernández‐López, D., García‐Yébenes, I., García‐Gutiérrez, M. S., Vivancos, J., Nombela, F., Torres, M., Burguete, M. C., Manzanares, J., Lizasoaín, I., et al. (2011) · Stroke · doi:10.1161/strokeaha.111.631044 · Cited by 217
Neuropathology of substance use disorders
Cadet, J. L., Bisagno, V., & Milroy, C. M. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1221-7 · Cited by 217
Xu, D. H., Cullen, B. D., Tang, M. Y., & Fang, Y. (2019) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201020666191202111534 · Cited by 217
The Cannabinoid System and Cytokine Network
Klein, T., Lane, B., Newton, C. A., & Friedman, H. P. (2000) · Proceedings of The Society for Experimental Biology and Medicine · doi:10.1046/j.1525-1373.2000.22501.x · Cited by 218
Aberrant cannabinoid signaling impairs oviductal transport of embryos
Wang, H., Guo, Y. X., Wang, D., Kingsley, P. J., Marnett, L. J., Das, S., DuBois, R. N., & Dey, S. K. (2004) · Nature Medicine · doi:10.1038/nm1104 · Cited by 217
Marzo, V. D., Melck, D. J., Orlando, P., Bisogno, T., Zagoory, O., Bifulco, M., Vogel, Z., & PETROCELLIS, L. D. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3580249 · Cited by 217
Brain cannabinoid receptor 2: expression, function and modulation
Chen, D., Gao, M., Gao, F., Quan-xi, S., & Wu, J. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2016.149 · Cited by 216
Activational role of cannabinoids on movement
Sañudo-Peña, M. C., Romero, J., Seale, G. E., Fernández‐Ruíz, J., & Walker, J. M. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00044-3 · Cited by 216
The obesity pipeline: current strategies in the development of anti-obesity drugs
Cooke, D., & Bloom, S. R. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2136 · Cited by 215
CB2receptor‐mediated migration of immune cells: it can go either way
Miller, A. M., & Stella, N. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707523 · Cited by 215
Adverse effects of cannabis and cannabinoids
Ashton, C. H. (1999) · British Journal of Anaesthesia · doi:10.1093/bja/83.4.637 · Cited by 214
Uhlenbrock, K., Gassenhuber, J., & Kostenis, E. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(02)00041-4 · Cited by 215
Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor
Shire, D. J., Calandra, B., Rinaldi, M. L., Oustric, D., Pessègue, B., Bonnin, O., Fur, G. L., Caput, D., & Ferrara, P. (1996) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(96)00047-4 · Cited by 214
Shoemaker, J. L., Seely, K. A., Reed, R. L., Crow, J. P., & Prather, P. L. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04346.x · Cited by 212
The CB1 Cannabinoid Receptor Is Coupled to the Activation of c-Jun N-Terminal Kinase
Rueda, D., Galve‐Roperh, I., Haro, A., & Guzmán, M. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.4.814 · Cited by 214
The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein coupling
Bayewitch, M. L., Avidor‐Reiss, T., Levy, R., Barg, J., Mechoulam, R., & Vogel, Z. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01207-u · Cited by 215
The Endocannabinoid System, Cannabinoids, and Pain
Fine, P. G., & Rosenfeld, M. J. (2013) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10129 · Cited by 213
Gorzalka, B. B., Hill, M. N., & Hillard, C. J. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.03.004 · Cited by 211
Endocannabinoids and Synaptic Function in the CNS
Hashimotodani, Y., Ohno‐Shosaku, T., & Kano, M. (2007) · The Neuroscientist · doi:10.1177/1073858406296716 · Cited by 210
The endocannabinoid signalling system: Biochemical aspects
Bisogno, T., Ligresti, A., & Marzo, V. D. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.027 · Cited by 211
The endocannabinoid system and cancer: therapeutic implication
Guindon, J., & Hohmann, A. G. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01327.x · Cited by 211
Cloning and Pharmacological Characterization of the Rat CB2 Cannabinoid Receptor
Griffin, G., Tao, Q., & Abood, M. E. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35367-4 · Cited by 210
Schmidt, B. L., Hamamoto, D. T., Simone, D. A., & Wilcox, G. L. (2010) · Molecular Interventions · doi:10.1124/mi.10.3.7 · Cited by 211
Häuser, W., Finn, D. P., Kalso, E. A., Krcevski‐Škvarč, N., Kress, H. G., Morlion, B. J., Perrot, S., Schäfer, M., Wells, C., & Brill, S. (2018) · European Journal of Pain · doi:10.1002/ejp.1297 · Cited by 211
Mitrirattanakul, S., Ramakul, N., Guerrero, A. V., Matsuka, Y., Ono, T., Iwase, H., Mackie, K., Faull, K. F., & Spigelman, I. (2006) · Pain · doi:10.1016/j.pain.2006.06.016 · Cited by 207
Progress in brain cannabinoid CB2 receptor research: From genes to behavior
Jordan, C. J., & Xi, Z. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.12.026 · Cited by 207
Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice
Martellotta, M. C., Cossu, G., Fattore, L., Gessa, G. L., & Fratta, W. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00052-9 · Cited by 205
Discovery and characterization of endogenous cannabinoids
Martin, B. R., Mechoulam, R., & Razdan, R. K. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00281-7 · Cited by 205
Modulation of pain transmission by G-protein-coupled receptors
Pan, H., Wu, Z.-Z., Zhou, H.-Y., Chen, S.-R., Zhang, H., & Li, D. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.09.003 · Cited by 204
Dysregulated Cannabinoid Signaling Disrupts Uterine Receptivity for Embryo Implantation
Paria, B. C., Song, H., Wang, X., Schmid, P. C., Krebsbach, R. J., Schmid, H. H. O., Bonner, T. I., Zimmer, A., & Dey, S. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100679200 · Cited by 204
The endogenous cannabinoid system and its role in nociceptive behavior
Cravatt, B. F., & Lichtman, A. H. (2004) · Journal of Neurobiology · doi:10.1002/neu.20080 · Cited by 203
A Lipid Pathway for Ligand Binding Is Necessary for a Cannabinoid G Protein-coupled Receptor
Hurst, D. P., Grossfield, A. M., Lynch, D. L., Feller, S. E., Romo, T. D., Gawrisch, K., Pitman, M. C., & Reggio, P. H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.041590 · Cited by 203
The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling
Tam, J., Trembovler, V., Marzo, V. D., Petrosino, S., Leo, G., Alexandrovich, A., Regev, E., Casap, N., Shteyer, A., Ledent, C. A., et al. (2007) · The FASEB Journal · doi:10.1096/fj.06-7957com · Cited by 203
Inhibition of Recombinant Human T-type Calcium Channels by Δ9-Tetrahydrocannabinol and Cannabidiol
Ross, H., Napier, I. A., & Connor, M. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707104200 · Cited by 203
Inhibitors of arachidonoyl ethanolamide hydrolysis.
Koutek, B., Prestwich, G. D., Howlett, A. C., Chin, S. A., Salehani, D., Akhavan, N., & Deutsch, D. G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31599-5 · Cited by 203
Cannabinoids and Pain: Sites and Mechanisms of Action
Starowicz, K., & Finn, D. P. (2017) · Advances in pharmacology · doi:10.1016/bs.apha.2017.05.003 · Cited by 203
Metadata
- Authors
- Munro, S., Thomas, K. L., & Abu-Shaar, M.
- Affiliations
- MRC Laboratory of Molecular Biology (GB)
- Venue
- Nature
- Published
- 1993-09
- Volume
- 365
- Issue
- 6441
- Pages
- 61-65
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2056188558
- Cited by
- 5,092
- References
- 30
- Citations by year
- 2026: 76 · 2025: 119 · 2024: 165 · 2023: 172 · 2022: 198 · 2021: 244 · 2020: 212 · 2019: 184 · 2018: 169 · 2017: 188 · 2016: 182 · 2015: 175 · 2014: 188 · 2013: 201 · 2012: 202
- FWCI
- 39.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- cannabinoid receptors, delta-9-tetrahydrocannabinol, peripheral cannabinoid receptors, macrophages, receptor cloning, G protein-coupled receptors, immunosuppression, anti-inflammatory activity
- MeSH terms
- Amides, Amino Acid Sequence, Animals, Arachidonic Acids, Base Sequence, Brain, Cannabinoids, Cloning, Molecular, DNA, Fatty Acids, Unsaturated, Humans, Macrophages, Molecular Sequence Data, Morpholines, Naphthalenes, Receptors, Drug, RNA, Spleen, Tumor Cells, Cultured, Receptors, Cannabinoid, Benzoxazines, Rats, Polyunsaturated Alkamides, Endocannabinoids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review